SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial (RCT) of vitamin D (VitD) combined with standard chemotherapy plus bevacizumab (bev) in patients (pts) with previously untreated metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Ng, K.; Ou, F. S.; Zemla, T.; McCleary, N.; Kalyan, A.; Shusterman, M.; Vijayvergia, N.; Wu, C.; Cohen, S. A.; Pulsipher, S.; Shergill, A.; Schwartz, L.; Zuckerman, D.; O'Reilly, E. M.; Meyerhardt, J. |
| Abstract Title: | SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial (RCT) of vitamin D (VitD) combined with standard chemotherapy plus bevacizumab (bev) in patients (pts) with previously untreated metastatic colorectal cancer (mCRC) |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | 1219 |
| Language: | English |
| ACCESSION: | WOS:001326612903034 |
| DOI: | 10.1016/j.annonc.2024.08.2265 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA26 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work